@article{angelin_qdenga_2023,
	title = {Qdenga® - {A} promising dengue fever vaccine; can it be recommended to non-immune travelers?},
	volume = {54},
	issn = {18730442},
	doi = {10.1016/j.tmaid.2023.102598},
	abstract = {Qdenga® has been approved by the European Medicines Agency (EMA) for individuals {\textgreater} 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical studies on 4–16-year old's living in endemic areas. For individuals 16–60 years old only serological data exists and there is no data for individuals {\textgreater} 60 years. Its use as a travel vaccine is still unclear. We present the studies behind the approval and the recommendations for travelers as issued by the Swedish Society for Infectious Diseases Physicians.},
	number = {May},
	journal = {Travel Medicine and Infectious Disease},
	author = {Angelin, Martin and Sjölin, Jan and Kahn, Fredrik and Hedberg, Anna Ljunghill and Rosdahl, Anja and Skorup, Paul and Werner, Simon and Woxenius, Susanne and Askling, Helena H.},
	year = {2023},
	pmid = {37271201},
	pages = {10--12},
}

{"_id":"amPwCo6Xxgw2ZPTpi","bibbaseid":"angelin-sjlin-kahn-hedberg-rosdahl-skorup-werner-woxenius-etal-qdengaapromisingdenguefevervaccinecanitberecommendedtononimmunetravelers-2023","author_short":["Angelin, M.","Sjölin, J.","Kahn, F.","Hedberg, A. L.","Rosdahl, A.","Skorup, P.","Werner, S.","Woxenius, S.","Askling, H. H."],"bibdata":{"bibtype":"article","type":"article","title":"Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?","volume":"54","issn":"18730442","doi":"10.1016/j.tmaid.2023.102598","abstract":"Qdenga® has been approved by the European Medicines Agency (EMA) for individuals \\textgreater 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical studies on 4–16-year old's living in endemic areas. For individuals 16–60 years old only serological data exists and there is no data for individuals \\textgreater 60 years. Its use as a travel vaccine is still unclear. We present the studies behind the approval and the recommendations for travelers as issued by the Swedish Society for Infectious Diseases Physicians.","number":"May","journal":"Travel Medicine and Infectious Disease","author":[{"propositions":[],"lastnames":["Angelin"],"firstnames":["Martin"],"suffixes":[]},{"propositions":[],"lastnames":["Sjölin"],"firstnames":["Jan"],"suffixes":[]},{"propositions":[],"lastnames":["Kahn"],"firstnames":["Fredrik"],"suffixes":[]},{"propositions":[],"lastnames":["Hedberg"],"firstnames":["Anna","Ljunghill"],"suffixes":[]},{"propositions":[],"lastnames":["Rosdahl"],"firstnames":["Anja"],"suffixes":[]},{"propositions":[],"lastnames":["Skorup"],"firstnames":["Paul"],"suffixes":[]},{"propositions":[],"lastnames":["Werner"],"firstnames":["Simon"],"suffixes":[]},{"propositions":[],"lastnames":["Woxenius"],"firstnames":["Susanne"],"suffixes":[]},{"propositions":[],"lastnames":["Askling"],"firstnames":["Helena","H."],"suffixes":[]}],"year":"2023","pmid":"37271201","pages":"10–12","bibtex":"@article{angelin_qdenga_2023,\n\ttitle = {Qdenga® - {A} promising dengue fever vaccine; can it be recommended to non-immune travelers?},\n\tvolume = {54},\n\tissn = {18730442},\n\tdoi = {10.1016/j.tmaid.2023.102598},\n\tabstract = {Qdenga® has been approved by the European Medicines Agency (EMA) for individuals {\\textgreater} 4 years of age and for use according to national recommendations. The vaccine shows high efficacy against virologically confirmed dengue and severe dengue in clinical studies on 4–16-year old's living in endemic areas. For individuals 16–60 years old only serological data exists and there is no data for individuals {\\textgreater} 60 years. Its use as a travel vaccine is still unclear. We present the studies behind the approval and the recommendations for travelers as issued by the Swedish Society for Infectious Diseases Physicians.},\n\tnumber = {May},\n\tjournal = {Travel Medicine and Infectious Disease},\n\tauthor = {Angelin, Martin and Sjölin, Jan and Kahn, Fredrik and Hedberg, Anna Ljunghill and Rosdahl, Anja and Skorup, Paul and Werner, Simon and Woxenius, Susanne and Askling, Helena H.},\n\tyear = {2023},\n\tpmid = {37271201},\n\tpages = {10--12},\n}\n\n\n\n","author_short":["Angelin, M.","Sjölin, J.","Kahn, F.","Hedberg, A. L.","Rosdahl, A.","Skorup, P.","Werner, S.","Woxenius, S.","Askling, H. H."],"key":"angelin_qdenga_2023-1","id":"angelin_qdenga_2023-1","bibbaseid":"angelin-sjlin-kahn-hedberg-rosdahl-skorup-werner-woxenius-etal-qdengaapromisingdenguefevervaccinecanitberecommendedtononimmunetravelers-2023","role":"author","urls":{},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/FRGBergamini","dataSources":["o2mL7kG99iAQPpNRJ"],"keywords":[],"search_terms":["qdenga","promising","dengue","fever","vaccine","recommended","non","immune","travelers","angelin","sjölin","kahn","hedberg","rosdahl","skorup","werner","woxenius","askling"],"title":"Qdenga® - A promising dengue fever vaccine; can it be recommended to non-immune travelers?","year":2023}